PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60

Autor:	Elena Parovichnikova, Irina Lukianova, Irina Galtzeva, Anastasiya Kashlakova, Zalina Fidarova, Olga Aleshina, Larisa Kuzmina, Vera Troitskaya, Mikhail Drokov, Andrey Sokolov, Sergej Bondarenko, Olga Samoilova, Mariya Grishunina, Tatiana Konstantinova, Yuliya Sveshnikova, Natalia Minaeva, Elena Zinina, Valerij Lapin, Kamil Kaplanov, Sergej Gritsaev, Elena Gribanova, Valentina Dvirnyk, Tatiana Obukhova, Andrej Sudarikov, Yuliya Chabaeva
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Diseases of the blood and blood-forming organs RC633-647.5
Zdroj:	HemaSphere, Vol 7, p e64022c0 (2023)
Druh dokumentu:	article
ISSN:	2572-9241
DOI:	10.1097/01.HS9.0000974300.64022.c0
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/7e45f48855404875a3a21cb787da5609 Zobrazit plný text záznamu Plný text View record in DOAJ